Comment on: Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients

被引：2
|
作者：
Barone, Federico [1 ,2 ]
Giacomelli, Andrea [1 ,2 ]
Casalini, Giacomo [2 ]
Corbellino, Mario
Lai, Alessia [1 ]
Gori, Andrea [1 ,3 ,4 ]
Antinori, Spinello [1 ,2 ]
机构：
[1] Univ Milan, Dipartimento Sci Biomed & Clin, Milan, Italy
[2] Luigi Sacco Hosp, Infect Dis Unit 3, ASST Fatebenefratelli Sacco, Milan, Italy
[3] Luigi Sacco Hosp, Infect Dis Unit 2, ASST Fatebenefratelli Sacco, Milan, Italy
[4] Univ Milan, Ctr Multidisciplinary Res Hlth Sci MACH, Milan, Italy
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2024年 / 79卷 / 09期
关键词：
D O I：
10.1093/jac/dkae234
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：2400 / 2402
页数：3
相关论文
共 50 条
  • [21] Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections
    Nooruzzaman, Mohammed
    Johnson, Katherine E. E.
    Rani, Ruchi
    Finkelsztein, Eli J.
    Caserta, Leonardo C.
    Kodiyanplakkal, Rosy P.
    Wang, Wei
    Hsu, Jingmei
    Salpietro, Maria T.
    Banakis, Stephanie
    Albert, Joshua
    Westblade, Lars F.
    Zanettini, Claudio
    Marchionni, Luigi
    Soave, Rosemary
    Ghedin, Elodie
    Diel, Diego G.
    Salvatore, Mirella
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [22] Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment
    Vellas, Camille
    Kamar, Nassim
    Izopet, Jacques
    JOURNAL OF INFECTION, 2022, 85 (05) : E162 - E163
  • [23] Assessing the post hoc effectiveness of tixagevimab-cilgavimab for prevention of SARS-CoV-2 infections in solid organ transplant recipients
    Jordan, Stanley C.
    Joung, Sandy Y.
    Wang, Minhao
    Tran, Teresa Anh
    Bravo, Michelle
    Masoom, Hibah
    Chang, Christine
    Mendez, Marilyn
    Patel, Jignesh
    Sun, Nancy
    Kittleson, Michelle
    Frias, Edwin
    Prostko, John C.
    Ebinger, Joseph E.
    Cheng, Susan
    Sobhani, Kimia
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (01)
  • [24] Tixagevimab-cilgavimab as pre-exposure prophylactic treatment against SARS-CoV-2 in kidney transplantation patients
    Gonzalez-Blas, Luis Bravo
    Garcia, Natalia Menendez
    Prada, Maria Fernandez
    Fraile, Maria Gago
    Fernandez, Maria Luisa Suarez
    Cano, Natalia Ridao
    NEFROLOGIA, 2024, 44 (03): : 396 - 401
  • [25] Arguments in favour of remdesivir for treating SARS-CoV-2 infections
    Ko, Wen-Chien
    Rolain, Jean-Marc
    Lee, Nan-Yao
    Chen, Po-Lin
    Huang, Ching-Tai
    Lee, Ping-Ing
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (04)
  • [26] SARS-CoV-2 viral load dynamics in immunocompromised critically ill patients on remdesivir treatment
    Latimer, Tobias
    Erber, Johanna
    Schmid, Roland M.
    Schneider, Jochen
    Spinner, Christoph D.
    Luppa, Peter
    Soergel, Fritz
    Kinzig, Martina
    Rasch, Sebastian
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2022, 17
  • [27] A Case Series of Persistent SARS-CoV-2 Infection in Immunocompromised Pediatric Patients
    Ahmed, M. Y.
    Taylor, J. B.
    Aneja, R.
    Wang, Q.
    Williams, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [28] Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions
    Duminuco, Andrea
    Nardo, Antonella
    Orofino, Alessandra
    Giunta, Giuliana
    Conticello, Concetta
    Del Fabro, Vittorio
    Chiarenza, Annalisa
    Parisi, Marina S.
    Figuera, Amalia
    Leotta, Salvatore
    Milone, Giuseppe
    Cupri, Alessandra
    Cambria, Daniela
    Di Raimondo, Francesco
    Romano, Alessandra
    Palumbo, Giuseppe A.
    CANCER, 2024, 130 (01) : 41 - 50
  • [29] Breakthrough SARS-CoV-2 infections among recipients of tixagevimab-cilgavimab prophylaxis: A citywide real-world effectiveness study
    Lendacki, Frances R.
    Li, Linda
    Forrest, Graeme N.
    Jordan, Leirah
    Zelinski, Christy
    Black, Stephanie R.
    Ison, Michael G.
    Seo, Jennifer Y.
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (01)
  • [30] Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
    Stuver, Robert
    Shah, Gunjan L.
    Korde, Neha S.
    Roeker, Lindsey E.
    Mato, Anthony R.
    Batlevi, Connie L.
    Chung, David J.
    Doddi, Sital
    Falchi, Lorenzo
    Gyurkocza, Boglarka
    Hamilton, Audrey
    Lin, Ya-Hui
    Jakubowski, Ann A.
    Joffe, Erel
    Landau, Heather L.
    Lin, Richard J.
    Mailankody, Sham
    Palomba, M. Lia
    Park, Jae H.
    Perales, Miguel-Angel
    Ponce, Doris M.
    V. Ramanathan, Lakshmi
    Salles, Gilles A.
    Scordo, Michael
    Seo, Susan K.
    Shah, Urvi A.
    Stein, Eytan M.
    Straus, David
    Usmani, Saad Z.
    Young, James W.
    Zelenetz, Andrew D.
    Noy, Ariela
    Vardhana, Santosha A.
    CANCER CELL, 2022, 40 (06) : 590 - 591
12345